 ጃንዋሪ 2018 ኤላፊብራራን በአዋቂዎች ውስጥ በናሽ ህክምና ውጤታማ መሆኑን የተረጋገጠ እና በልጆች ህክምና ውስጥ በእድገት ደረጃ ላይ የሚገኝ ብቸኛ መድሃኒት መሆኑን ከግምት ውስጥ በማስገባት የናሽ የሕፃናት መርሃግብር በይፋ ይጀምራል ።
In January 2018 there was the official launching of NASH pediatric program having in mind that Elafibranor is the only drug that has proven to be effective in NASH treatment in adults and is in the development stage in the treatment of children.